What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News Chronos-3 trial results : Aliqopa, rituximab combo meets primary endpoint of PFS, says Bayer Chronos-3 trial results : Bayer said that the investigational combination of Aliqopa (copanlisib) and rituximab considerably increased progression-free… bySrinathApril 11, 2021
